A bit of antithymocyte globulins can take you a long way!
Metabolic syndrome and cardiovascular risk in survivors after hematopoietic cell transplantation
Assessing causal relationships between treatments and clinical outcomes: always read the fine print
Intravenous compared with oral busulfan as preparation for allogeneic hematopoietic progenitor cell transplantation for AML and MDS
The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT
Reduced-intensity conditioning hematopoietic SCT for pediatric patients with LAD-1: clinical efficacy and importance of chimerism
Evaluation of oxidative and antioxidative parameters in pediatric hematopoietic SCT patients
Decreased bone mineral density in young adults treated with SCT in childhood: the role of 25-hydroxyvitamin D
Feasibility and outcome of haploidentical SCT in pediatric high-risk hematologic malignancies and Fanconi anemia in Uruguay
Incidence of extramedullary relapse after haploidentical SCT for advanced AML/myelodysplastic syndrome
Access to allogeneic hematopoietic SCT for patients with MDS or relapsed AML treated according to protocols of the Dutch Childhood Oncology Group
Growth hormone treatment impact on growth rate and final height of patients who received HSCT with TBI or/and cranial irradiation in childhood: a report from the French Leukaemia Long-Term Follow-Up Study (LEA)
Serial intestinal endoscopic examinations of patients with persistent diarrhea after allo-SCT
Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation
Increased costs after allogeneic haematopoietic SCT are associated with major complications and re-transplantation
The impact of hematopoietic stem cell transplantation on sexuality: a systematic review of the literature
The effect of oral management on the severity of oral mucositis during hematopoietic SCT
Immunohistochemistry of affected tissue may guide cGVHD treatment decisions
Disseminated Geosmithia argillacea infection in a patient with gastrointestinal GvHD
Lack of efficacy of rituximab in refractory sclerodermatous chronic GVHD
Oral cryotherapy can significantly reduce oral mucositis but not acute GVHD incidence in Flu/Mel conditioning allo-SCT
Non-myeloablative allogenic BMT for myelodysplastic syndrome successfully controlled accompanying relapsing polychondritis
T-cell-depleted hematopoietic SCT from unrelated donors for the treatment of congenital amegakaryocytic thrombocytopenia
Ustekinumab demonstrates activity in glucocorticoid-refractory acute GVHD